September 8, 2022
Six generic makers on September 7 earned an additional indication for their versions of Otsuka Pharmaceutical’s diuretic agent Samsca (tolvaptan) for use in heart failure patients in Japan, including an authorized generic (AG). The approval was announced for Tolvaptan OD...read more